Research this month concludes: "A randomized, phase 2 clinical trial shows that adding high-dose, intravenous (IV) vitamin C to chemotherapy doubles the overall survival of patients with late-stage metastatic pancreatic cancer from eight months to 16 months. The finding adds to mounting evidence of the benefits of high-dose, IV vitamin C in treating cancer."
https://www.sciencedaily.com/releases/2024/11/241118125040.htm#google_vignette
https://www.sciencedaily.com/releases/2024/11/241118125040.htm#google_vignette
Wow as author Jane McLelland says: "Who has been told by their doctor not to waste your money on intravenous vitamin C? This study should be HEADLINES in every paper as it DOUBLES survival times. If it were a patented drug the excitement would be intense....My lowest ever cancer markers when I had stage 4 was when I took a combination of dugs/supplements with IVC. IVC should not be considered "alternative" it should be considered as a standard treatment.....IVC works by increasing #ferroptosis which you are not allowed to know about as my second edition which discusses this topic is still deemed 'offensive' by @amazon and is still not reinstated. Shame on you. Pancreatic cancer is one of the worst diagnoses."
No comments:
Post a Comment